Stoke Therapeutics, Inc.

STOK · Healthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression

Stoke Therapeutics, Inc. (STOK), in the Healthcare sector, has 20 disclosed filings on Paydirt over the trailing twelve months from 5 corporate insiders: 0 purchases and 20 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 1 and filed Sep 3. The most active filer was Barry Ticho with 12 filings.

Add to watchlist

Filings, ttm

0 buys · 20 sells

Traders, ttm

5 insiders

Volume, ttmiDollar value disclosed in the window

$9.0M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 1

Filed Sep 3

ADViAverage daily dollar volume

$25.8M

market data

Share price · 12M

$29.81 (+30.5%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $65.8M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Barry Ticho CHIEF MEDICAL OFFICER 12 filings JA

Jonathan Allan GENERAL COUNSEL & CORP SEC 8 filings EK

Edward M. MD Kaye Director 7 filings AK

Adrian R. Krainer Director 4 filings BL Blue Horizon Enterprise Ltd 10% owner 2 filings ST Skorpios Trust 10% owner 1 filing AT

Arthur Tzianabos Interim Executive Chair 1 filing

Recent filings

Barry TichoSALE CHIEF MEDICAL OFFICER $120K
3,945 sh × $30.51
Exec Sep 1
Filed Sep 3 · 4:17 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $145K
4,525 sh × $32.01
Exec Aug 18
Filed Aug 18 · 8:29 PM ET Edward M. MD KayeSALE Director $382K
11,930 sh × $32.01
Exec Aug 18
Filed Aug 18 · 8:28 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $171K
5,907 sh × $28.95
Exec Aug 3
Filed Aug 5 · 4:17 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $219K
6,728 sh × $32.62
Exec Jul 1
Filed Jul 6 · 4:10 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $292K
8,692 sh × $33.64
Exec Mar 20
Filed Mar 24 · 5:30 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $132K
4,222 sh × $31.28
Exec Mar 18
Filed Mar 19 · 5:30 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $308K
9,677 sh across 2 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET Adrian R. KrainerSALE Director $1.3M
33,243 sh × $39.74
Exec Mar 10
Filed Mar 12 · 5:30 PM ET Arthur TzianabosSALE Interim Executive Chair $174K
4,355 sh × $40.00
Exec Mar 10
Filed Mar 12 · 5:30 PM ET Adrian R. KrainerSALE Director $287K
7,229 sh × $39.66
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Edward M. MD KayeSALE Director $389K
12,099 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $169K
5,437 sh × $31.08
Exec Dec 5 2025
Filed Dec 5 2025 · 5:30 PM ET Edward M. MD KayeSALE Director $360K
11,589 sh across 2 lots
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET Adrian R. KrainerSALE Director $1.2M
40,472 sh × $29.72
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET Adrian R. KrainerSALE Director $1.1M
40,472 sh across 2 lots
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET Edward M. MD KayeSALE Director $750K
25,000 sh × $30.00
Exec Oct 8 2025
Filed Oct 10 2025 · 5:30 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $251K
10,000 sh × $25.07
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET Edward M. MD KayeSALE Director $1.1M
42,461 sh × $25.09
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $126K
5,343 sh × $23.64
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $428K
21,267 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET Edward M. MD KayeSALE Director $1.2M
60,856 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET Barry TichoSALE CHIEF MEDICAL OFFICER $109K
5,501 sh × $19.87
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET Edward M. MD KayeSALE Director $221K
12,126 sh × $18.24
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET Jonathan AllanSALE GENERAL COUNSEL & CORP SEC $206K
13,712 sh × $15.00
Exec Aug 13 2025
Filed Aug 15 2025 · 5:30 PM ET